Levels of Synaptic Proteins in Brain and Neurofilament Light Chain in Cerebrospinal Fluid and Plasma of OVT73 Huntington's Disease Sheep Support a Prodromal Disease State

被引:1
|
作者
Sapp, Ellen [1 ]
Boudi, Adel [1 ]
Reid, Suzanne J. [2 ]
Trombetta, Bianca A. [3 ]
Kivisakk, Pia [3 ]
Taghian, Toloo [4 ,5 ]
Arnold, Steven E. [3 ]
Howland, David [6 ]
Gray-Edwards, Heather
Kegel-Gleason, Kimberly B. [1 ]
DiFiglia, Marian [1 ]
机构
[1] Harvard Med Sch, MassGeneral Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA
[2] Univ Auckland, Sch Biol Sci, Ctr Brain Res, Auckland, New Zealand
[3] Harvard Med Sch, Massachusetts Gen Hosp, Alzheimers Clin & Translat Res Unit, Dept Neurol, Boston, MA USA
[4] Univ Massachusetts, Dept Radiol, Chan Med Sch, Worcester, MA USA
[5] Univ Massachusetts, Horae Gene Therapy Ctr, Chan Med Sch, Worcester, MA USA
[6] CHDI Fdn, CHDI Management, New York, NY USA
关键词
Huntington's disease; HD sheep; caudate; putamen; synaptosomes; neurofilament light chain levels; cerebrospinal fluid; HUMAN MUTANT HUNTINGTIN; POLYGLUTAMINE REPEAT; ANIMAL-MODELS; MOUSE MODEL; EARLY MOTOR; CALMODULIN; PROTEOMICS; REVEALS; MICE;
D O I
10.3233/JHD-230590
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Synaptic changes occur early in patients with Huntington's disease (HD) and in mouse models of HD. An analysis of synaptic changes in HD transgenic sheep (OVT73) is fitting since they have been shown to have some phenotypes. They also have larger brains, longer lifespan, and greater motor and cognitive capacities more aligned with humans, and can provide abundant biofluids for in vivo monitoring of therapeutic interventions. Objective: The objective of this study was to determine if there were differences between 5- and 10-year-old OVT73 and wild-type (WT) sheep in levels of synaptic proteins in brain and in neurofilament light chain (NfL) in cerebrospinal fluid (CSF) and plasma. Methods: Mutant huntingtin (mHTT) and other proteins were measured by western blot assay in synaptosomes prepared from caudate, motor, and piriform cortex in 5-year-old and caudate, putamen, motor; and piriform cortex in 10-year-old WT and OVT73 sheep. Levels of NfL, a biomarker for neuronal damage increased in many neurological disorders including HD, were examined in CSF and plasma samples from 10-year-old WT and OVT73 sheep using the Simoa NfL Advantage kit. Results: Western blot analysis showed mHTT protein expression in synaptosomes from OVT73 sheep was 23% of endogenous sheep HTT levels at both ages. Significant changes were detected in brain levels of PDE10A, SCN4B, DARPP32, calmodulin, SNAP25, PSD95, VGLUT1, VAMP1, and Na+/K+-ATPase, which depended on age and brain region. There was no difference in NfL levels in CSF and plasma in OVT73 sheep compared to age-matched WT sheep. Conclusions: These results show that synaptic changes occur in brain of 5- and 10-year-old OVT73 sheep, but levels of NfL in biofluids are unaffected. Altogether, the data support a prodromal disease state in OVT73 sheep that involves the caudate, putamen and cortex.
引用
收藏
页码:201 / 213
页数:13
相关论文
共 50 条
  • [31] Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in Alzheimer's disease patients
    Pinol-Ripoll, G.
    Targa, A.
    Benitez, I.
    Dakterzada, F.
    Lopez, R.
    Barbe, F.
    JOURNAL OF SLEEP RESEARCH, 2020, 29 : 21 - 21
  • [32] Neurofilament Light Chain in Blood as a Predictor of Onset, Progression, and Brain Atrophy in Huntington's Disease: A Longitudinal Cohort Analysis
    Byrne, Lauren M.
    Rodrigues, Filipe B.
    Blennow, Kaj
    Durr, Alexandra
    Leavitt, Blair R.
    Roos, Raymund A. C.
    Scahill, Rachael I.
    Tabrizi, Sarah J.
    Zetterberg, Henrik
    Langbehn, Douglas
    Wild, Edward J.
    NEUROTHERAPEUTICS, 2018, 15 (01) : 236 - 237
  • [33] Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer's disease
    Santangelo, Roberto
    Agosta, Federica
    Masi, Francesco
    Spinelli, Edoardo Gioele
    Cecchetti, Giordano
    Caso, Francesca
    Mandelli, Alessandra
    Cardamone, Rosalinda
    Barbieri, Alessandra
    Furlan, Roberto
    Magnani, Giuseppe
    Filippi, Massimo
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (09) : 2980 - 2988
  • [34] Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease
    Zhu, Yongyun
    Yang, Baiyuan
    Wang, Fang
    Liu, Bin
    Li, Kelu
    Yin, Kangfu
    Yin, Wei Fang
    Zhou, Chuanbin
    Tian, Sijia
    Ren, Hui
    Pang, Ailan
    Yang, Xinglong
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 358
  • [35] Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia
    Giuffre, Guido Maria
    Quaranta, Davide
    Costantini, Emanuele Maria
    Citro, Salvatore
    Martellacci, Noemi
    De Ninno, Grazia
    Vita, Maria Gabriella
    Guglielmi, Valeria
    Rossini, Paolo Maria
    Calabresi, Paolo
    Marra, Camillo
    NEUROBIOLOGY OF DISEASE, 2023, 186
  • [36] Plasma Neurofilament Light (NfL) Levels Do Not Correlate with Severity of Clinical Symptoms in Manifest Huntington's Disease (HD)
    Corey-Bloom, Jody
    Parkin, Georgia M.
    Snell, Chase
    Castleton, Jordan
    Thomas, Elizabeth
    NEUROLOGY, 2021, 96 (15)
  • [37] Cerebrospinal Fluid and Blood Neurofilament Light Chain Protein in Prion Disease and Other Rapidly Progressive Dementias: Current State of the Art
    Abu-Rumeileh, Samir
    Parchi, Piero
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [38] Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases
    Kawarabayashi, Takeshi
    Nakamur, Takumi
    Miyashit, Kazuya
    Segaw, Tatsuya
    Fukamachi, Isamu
    Sugawara, Takashi
    Oka, Hironori
    Ishizawa, Kunihiko
    Amari, Masakuni
    Kasahara, Hiroo
    Makioka, Kouki
    Ikeda, Yoshio
    Takatama, Masamitsu
    Shoji, Mikio
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 96 (04) : 1623 - 1638
  • [39] Increased neurofilament light chain plasma levels as a biological marker of mild cognitive impairment in Parkinson's disease
    Pagonabarraga, J.
    Perez-Gonzalez, R.
    Bejr-Kasem, H.
    Marin-Lahoz, J.
    Horta-Barba, A.
    Aracil-Bolanos, I.
    Sampedro, F.
    Martinez-Horta, S.
    Perez-Perez, J.
    Pascual-Sedano, B.
    Kulisevsky, J.
    MOVEMENT DISORDERS, 2020, 35 : S181 - S181
  • [40] Prodromal Alzheimer's Disease: Global Cognition, Cue Efficiency, and Cerebrospinal Fluid Neurofilament Light Values Predict Short-Term Conversion to Dementia
    Mendez-Barrio, Carlota
    Medina-Rodriguez, Manuel
    Mendoza-Vazquez, Gonzalo
    Garcia-Roldan, Ernesto
    Rodrigo-Herrero, Silvia
    Luque-Tirado, Andrea
    Almodovar-Sierra, Angela
    Franco-Macias, Emilio
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 (03) : 877 - 887